Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Boris K. Lin"'
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure 2. LSN2478185 increases body weight and muscle mass in non-tumor-bearing mice in the presence of gemcitabine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f733f2d7931c4e420f8a2476db4746
https://doi.org/10.1158/1535-7163.22502031
https://doi.org/10.1158/1535-7163.22502031
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb9521c24ade70e85df497204816b54
https://doi.org/10.1158/1535-7163.22502016
https://doi.org/10.1158/1535-7163.22502016
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure 4. LY2495655 attenuates loss of muscle weight normalized to brain weight but has no effect on brain or heart weight in C26 tumor bearing mice in the presence of gemcitabine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e850e99e41cb002434d624cdadefc2bd
https://doi.org/10.1158/1535-7163.22502025.v1
https://doi.org/10.1158/1535-7163.22502025.v1
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure 1. LSN2478185 and LY2495655 neutralize 1nM myostatin in an SBE luciferase assay in HEK-293 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d6d8af85c853e71862ead3a845c277
https://doi.org/10.1158/1535-7163.22502034
https://doi.org/10.1158/1535-7163.22502034
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure 5. Loss of body weight, muscle mass and strength in the PC3 tumor model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01a0318b42e7139f889026dcf4ce83c
https://doi.org/10.1158/1535-7163.22502022.v1
https://doi.org/10.1158/1535-7163.22502022.v1
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure 6. LY2495655 attenuates the loss of muscle weight normalized to brain weight in the PC3 tumor model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7155040030bd4043d30c1a7d9f2264cf
https://doi.org/10.1158/1535-7163.22502019.v1
https://doi.org/10.1158/1535-7163.22502019.v1
Autor:
Josef G. Heuer, Boris K. Lin, Victor J. Wroblewski, Kelly M. Credille, Jeff Hanson, Darryl Ballard, Brian J. Eastwood, Bryan E. Jones, Laura Myers, Rong Wang, Lysiane Huber, Andrew Capen, Pamela J. Mitchell, Martin S. Cramer, Rosamund C. Smith
Supplementary Figure 3. LSN2478185 reduces the loss of skeletal muscle mass under conditions of caloric restriction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e536748b6be5b02061b38b661cb3c544
https://doi.org/10.1158/1535-7163.22502028.v1
https://doi.org/10.1158/1535-7163.22502028.v1
Autor:
Klaus Podar, Kenneth C. Anderson, Nikhil Munshi, Teru Hideshima, Dharminder Chauhan, Boris K Lin, Johannes Fruehauf, Jing Zhang, Giovanni Tonon, Iris Breitkreutz, Marc S Raab
Publikováno v:
Blood. 112:2763-2763
Targeting protein kinase C (PKC) isoforms by the small molecule inhibitor enzastaurin has shown promising pre-clinical activity in a wide range of tumor cells. In this study, we further delineated its mechanism of action in multiple myeloma (MM) cell